The induction of cell death by aspirin was analysed in HT-29 colon carcinoma cells. Aspirin induced two hallmarks of apoptosis: nuclear chromatin condensation and increase in phosphatidylserine externalization. However, aspirin did not induce either oligonucleosomal fragmentation of DNA, decrease in DNA content or nuclear fragmentation. The effect of aspirin on Annexin V binding was inhibited by the caspase inhibitor Z-VAD.fmk, indicating the involvement of caspases in the apoptotic action of aspirin. However, aspirin did not induce proteolysis of PARP, suggesting that aspirin does not increase nuclear caspase 3-like activity in HT-29 cells. This finding may be related with the 'atypical' features of aspirin-induced apoptosis in HT-29 cells.
tion of colorectal cancer by NSAIDs is not completely understood. Different mechanisms have been proposed, including inhibition of cell proliferation, inhibition of carcinogen production, potentiation of immune response, inhibition of angiogenesis and induction of apoptosis (Shiff and Rigas, 1997; Tsujii et al, 1998) . These mechanisms are not exclusive and the effect of NSAIDs on the biology of cancer cells may depend on a combination of them.
Apoptosis is critical for the control of colon epithelial cell number (Hall et al, 1994) . The evidence obtained in recent years indicates that many cancer chemotherapy agents induce apoptosis of tumour cells (Hannun, 1997) . NSAIDs induce apoptosis of different cell types, including human colorectal tumour cell lines (Piazza et al, 1995; Shiff et al, 1995; Elder et al, 1996) and rat enterocytes (Arber et al, 1997) . Furthermore, administration of NSAIDs induces apoptosis of colon cancer cells in vivo (Pasricha et al, 1995; Boolbol et al, 1996) . The mechanism responsible for this apoptotic effect of NSAIDs is not clear. Aspirin and other NSAIDs directly target cyclooxygenase (COX) (Vane, 1971) , a key enzyme in the production of prostaglandins, prostacyclins and thomboxanes (Smith, 1989) . Although COX is the molecular target of most NSAIDs, both COX-dependent and COX-independent mechanisms in the apoptotic action of NSAIDs have been reported (Shiff and Rigas, 1997; Elder and Paraskeva, 1998; Gupta and DuBois, 1998) .
Whether or not aspirin induces apoptosis is still controversial. It has been reported that aspirin, in contrast to other NSAIDs, does not induce apoptosis either in colon carcinoma HT-29 cells (Shiff et al, 1996; Piazza et al, 1997) , or in v-src-transformed chicken fibroblasts (Lu et al, 1995) . However, we found that in B-CLL cells aspirin induces all the typical features of apoptosis, including internucleosomal DNA fragmentation, decrease in DNA content, increase in phosphatidylserine exposure and proteolysis of poly(ADPribose) polymerase (PARP) (Bellosillo et al, 1998) . Consistent with our results, it has been reported that aspirin induces apoptosis of colon adenocarcinoma Caco-2 cells (Ricchi et al, 1997) , HT-29 cells (Qiao et al, 1998 ) and crypt cells (Barnes et al, 1998) . The apoptotic action of aspirin on B-CLL cells was inhibited by the caspase inhibitor Z-VAD.fmk, demonstrating the involvement of caspases (Bellosillo et al, 1998) . Caspases are responsible for many of the biochemical and morphological processes during apoptosis, including DNA fragmentation, phosphatidylserine exposure, degradation of nuclear lamins, nuclear morphological changes, and proteolysis of PARP and other enzymes involved in DNA repair and genomic stability (Cohen, 1997; Cryns and Yuan, 1998) .
In HT-29 cells, the cell death induced by aspirin was associated neither with a ladder pattern in genomic DNA electrophoresis nor with a subdiploid peak in flow cytometry, so it was considered 'atypical apoptosis' (Qiao et al, 1998) . A very recent report concludes that necrosis rather than apoptosis is the mechanism that accounts for aspirin toxicity in human colon SW 620 and HT-29 cells (Subbegowda and Frommel et al, 1998) .
Aspirin is one of the most widely studied NSAIDs in the prevention of colon cancer. Thus, from the viewpoint of colon cancer chemotherapy it is important to reveal the mechanism of aspirin-induced cell death. Furthermore, for in vitro studies of colon cancer chemotherapy-induced apoptosis, the human colonic adenocarcinoma cell line HT-29 is a valuable tool. The aim of this study was to further analyse the induction of cell death by aspirin in HT-29 cells, focusing on the effect of aspirin on the activation of caspases.
Aspirin induces cell death and caspase-dependent phosphatidylserine externalization in HT-29 human colon adenocarcinoma cells 
MATERIALS AND METHODS

Reagents
Aspirin (acetylsalicylic acid), 3,(4,5-dimethylthiazol-2-yl)2,4-diphenyltetrazolium bromide (MTT) and propidium iodide were obtained from Sigma (St Louis, MO, USA). Fetal calf serum (FCS) was from Gibco Laboratories and Dulbecco's modified Eagle's medium (DMEM) was from Biological Industries. Nbenzyloxycarbonyl-Val-Ala-Asp-fluoromethyl ketone (Z-VAD.fmk) was obtained from Enzyme Systems Products (Dublin, CA, USA). Annexin V-FITC was obtained from Boehinger Ingelheim. PARP polyclonal antibody (Vi.5) raised against the recombinant human PARP over-produced in Sf 9/baculovirus was kindly provided by Dr Gilbert de Murcia (Strasbourg, France). All the other reagents were of analytical grade.
Cell culture
The human colon adenocarcinoma cell line HT-29 (ATCC HTB 28) was obtained from the European Type Culture Collection. Stock cultures of cells were maintained in DMEM supplemented with 10% FCS, L-glutamine (2 mM), penicillin (100 units ml -1 ) and streptomycin (100 µg ml -1 ) in a humidified atmosphere of 10% carbon dioxide/90% air at 37°C. To obtain cultures for experimental purposes, cells were plated at 25 000 or 50 000 cells cm -2 . Assays using preconfluent conditions were treated by adding the appropriate amount of drug stock solution directly to the media in absence of FCS the day after plating at the described densities.
Cell number assay
Cell number was determined by the MTT assay (Mosmann, 1983) . HT-29 cells (20 000 cells per well) were incubated in 24-well plates in the absence or in the presence of factors in a final volume of 500 µl. At different times, 50 µl of MTT (5 mg ml -1 in phosphate-buffered saline (PBS) was added to each well for a further 3 h. The blue MTT formazan precipitated was dissolved in 500 µl of isopropanol: 1 M hydrochloric acid (24:1) and the absorbance values at 570 nm were determined on a multiwell plate reader.
Apoptosis
In all experiments floating and freshly trypsinized cells were pooled and apoptosis was evaluated by the following assays.
Measurement of the annexin-V and propidium iodide staining by FACS analysis Cells were washed twice in binding buffer (10 mM HEPESsodium hydroxide pH 7.4, 140 mM sodium chloride, 2.5 mM calcium chloride, and resuspended in the same buffer at 10 6 cells ml -1 in the presence of 0.5 µl of annexin-V-FITC. After 30 min of incubation at room temperature, propidium iodine (PI) was added at 0.05 µg ml -1 . The fluorescence of cells was analysed by flow cytometry (FACSCalibur, Becton Dickinson, Mountain View, CA, USA), using the Cell Quest software.
Measurement of cell detachment
HT-29 cells (200 000 cells per well) were incubated in 35-mm dishes in the absence or in the presence of factors in a final volume of 2 ml. The total number of floating and attached cells was determined by microscopy using the Neubauer micro slide.
Western blot analysis of PARP
Cells were plated onto 100 cm 2 dishes at a density of 5 × 10 6 cells per dish. After washing the cultures with PBS, they were lysed with Laemmli sample buffer (Laemmli, 1970) and samples were incubated for 10 min at 100°C.
Protein concentration was determinated by the BCA Protein Assay (Pierce, Rockford, IL, USA). Fifty micrograms of the protein extract was subjected to sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE), and transferred to Immobilon-P membranes (Millipore, Bedford, MA, USA). After blocking for 1 h with 5% dried skimmed milk in TBST (50 mM Tris-HCl pH 8, 150 mM sodium chloride, 0.5% Tween-20), the filters were incubated with Vi.2 antibody diluted 1:1000 in 5% dried skimmed milk in TBST. Antibody binding was detected by using a secondary antibody (anti-rabbit immunoglobulin, Amersham, Buckinghamshire, UK) conjugated to horseradish peroxidase diluted 1:5000 in 5% dried skimmed milk in TBST and an enhanced chemiluminescence (ECL) detection kit (Amersham, Buckinghamshire, UK).
Data analysis
All data points shown are mean values ± s.e.m. of n independent experiments. The data points from duplicates or triplicates of an individual experiments were averaged, and the data points shown are the mean of these averages from n experiments. Statistical significance of differences was assessed by ANOVA (Fisher PLSD test) . Differences between absence and presence of aspirin are indicated by (*) P < 0.05, (**) P < 0.01 and (***) P < 0.001.
RESULTS
Cytotoxic effect of aspirin on HT-29 cells
We first studied the cytotoxic effect of aspirin on HT-29 cells. Cells were incubated for 72 h with different aspirin concentrations, ranging from 0 to 10 mM, and the number of viable cells was determined by the MTT assay. The decrease in cell number was dosedependent ( Figure 1A) . The mean IC 50 of these dose-response studies was 5 mM. In agreement with previous studies (Shiff et al, 1996; Qiao et al, 1998) , aspirin treatment induced an increase in the G0/G1 phase of the cell cycle (results not shown). As aspirin inhibits proliferation, only a decrease in the number of cells with respect to time zero necessarily implies an increase in cell death. Thus, the cytotoxicity of aspirin on HT-29 cells was studied with time-course assays. A significant increase in cell death was observed after 48 h of incubation with 10 mM aspirin ( Figure 1B) .
Characterization of aspirin-induced cell death in HT-29 cells
We next studied the characteristics of aspirin-induced cell death in HT-29 cells. The appearance of apoptotic cells was analysed in treated cultures according to morphological criteria (Duke and Cohen, 1992) . The addition of aspirin to HT-29 cells induced morphological changes characteristic of apoptosis, including cell shrinkage and strong condensation of nuclei (data not shown). However, nuclear fragmentation or apoptotic bodies were not observed. Consistent with a previous report (Qiao et al, 1998) , cells treated with several concentrations of aspirin did not show evidence of a ladder pattern of their genomic DNA when analysed by agarose gel electrophoresis, nor a decrease in DNA content when analysed by flow cytometry (data not shown).
To corroborate the induction of apoptosis by aspirin in HT-29 cells, the externalization of phosphatidylserine was studied with the annexin V-binding assay (van Engeland et al, 1998) . The affinity of annexin V for the PS residues allows the percentage of cells undergoing apoptosis to be quantified by flow cytometry. Apoptotic and necrotic cells were distinguished on the basis of a double-labelling for annexin V-FITC and PI, a membrane impermeable DNA stain. Aspirin induced a dose-dependent increase in the percentage of apoptotic cells (annexin V-positive/PI-negative), when treated for 24 h (Figure 2) . In contrast, the number of necrotic (annexin V-positive/PI-positive) and damaged (annexin V-negative/PI-positive) cells was not significantly increased (P > 0.05). At 48 h and 72 h an increase in the double positive population was detected ( Figure 2B ). This effect is consistent with the secondary necrosis process, which usually comes after apoptosis in cell cultures. These results demonstrate that aspirin induces apoptosis of HT-29 cells.
Involvement of caspases in the apoptotic effect of aspirin
We analysed whether incubation of HT-29 cells with aspirin induced proteolytic cleavage of PARP, a hallmark of activation of caspase-3 like proteases during apoptosis. Incubation of HT-29 cells for 72 h with various doses of aspirin, ranging from 2.5 to 10 mM, induced a decrease in the cellular levels of PARP without detectable proteolysis (Figure 3 ). Proteolytic cleavage of PARP was not detected at 24 h or at 48 h (data not shown). As positive controls we used HT-29 cells treated with 1 µM staurosporine (Figure 3 ) and aspirin-treated B-CLL cells (data not shown) which revealed the 85 kDa fragment of PARP.
Apoptosis-induced PS exposure is prevented by caspase inhibitors Vanags et al, 1996) . In order to assess the involvement of caspases in the apoptotic effect of aspirin, we studied whether the caspase inhibitor Z-VAD.fmk prevented aspirin-induced PS externalization. HT-29 cultures were incubated for 24 h and 48 h with different concentrations of aspirin in the presence or absence of 200 µM Z-VAD.fmk, which had no cytotoxic effects. Z-VAD.fmk prevented the increase in annexin+/IPϪcells induced by aspirin at all concentrations used ( Figure 4A ). Furthermore, Z-VAD.fmk also prevented aspirininduced cell detachment in HT-29 cells ( Figure 4B ).
DISCUSSION
The results shown in this report demonstrate that aspirin induces caspase-dependent externalization of phosphatidylserine in HT-29 cells. It has been described that the loss of membrane asymmetry during the apoptotic process results in the exposure of phosphatidylserine (PS) at the outer plasma membrane leaflet of the cell, a fundamental characteristic that distinguishes apoptosis from necrosis (reviewed in Van Engeland et al, 1998) . This is a very early phenomenon, which follows caspase activation but probably precedes nuclear condensation. Aspirin-induced PS externalization can be blocked by caspase inhibitors, demonstrating the involvement of caspases. Furthermore, in agreement with previous reports (Elder et al, 1996; Qiao et al, 1998) , aspirin induced cell detachment and morphological changes characteristic of apoptosis in HT-29 cells. Considering these results, we can conclude that aspirin induces an apoptotic process in HT-29 colonic carcinoma cells. Although HT-29 cells express caspase-3, we did not detect cleavage of PARP by caspase-3-like proteases during aspirininduced apoptosis in HT-29 cells. This finding could be related with the 'atypical' apoptotic features of aspirin-induced cell death in these cells. Some cell types from caspase-3 knockout mice are incapable of DNA degradation, but display other hallmarks of apoptosis, like PS externalization (Woo et al, 1998) . Furthermore, the MCF-7 breast carcinoma cell line, which does not express caspase-3 (Janicke et al, 1998; Zapata et al, 1998) , undergoes apoptosis in the absence of DNA fragmentation (Oberhammer et al, 1993; Janicke et al, 1998) , but showing PS externalization (Mangiarotti et al, 1998) . Interestingly, MCF-7 cells treated with the NSAID sulindac show nuclear condensation without clear DNA ladder (Han et al, 1998) .
The inability of aspirin to induce some of the biochemical characteristics of apoptosis in HT-29 cells may be signal-specific, since 7-hydroxystaurosporine (Shao et al, 1997) , butyrate (Heerdt et al, 1994) , Fas (Bonnotte et al, 1998) and intestinal trefoil factor 3 (Efstathiou et al, 1998) induce oligonucleosomal fragmentation of DNA in HT-29 cells. On the other hand, nitrogen mustard induces apoptosis of HT-29 cells in the absence of DNA laddering (Boddie et al, 1998) .
The mechanisms by which NSAIDs induce apoptosis are not clear. Consistent with the hypothesis that the apoptotic action of NSAIDs is mediated by the inhibition of COX, overexpression of COX-2 in rat epithelial intestinal cells inhibits butyrate-induced apoptosis and this inhibition was reversed by the NSAID sulindac sulphide (Tsujii and DuBois, 1995) . However, the sulfone metabolite of sulindac, which does not inhibit cyclooxygenases, also induces apoptosis of HT-29 cells (Piazza et al, 1995) , and COX-2 selective inhibitors induce apoptosis in human colorectal carcinoma cell lines independently of COX-2 protein expression (Elder et al, 1997) . Taken together these results suggest the contribution of COX-dependent and COX-independent mechanisms in the apoptotic action of NSAIDs. Interestingly, we have recently demonstrated that aspirin inhibits DNA synthesis in Swiss 3T3 fibroblasts by both COX-dependent and COX-independent mechanisms, depending on the concentration used (Castaño et al, 1997) . Cyclooxygenase-independent mechanisms have been implicated in the inhibition of the transcription factor NF-κB by aspirin and salicylate (Kopp and Ghosh, 1994; Schwenger et al, 1998) . Very recently, it has been reported that aspirin binds and inhibits IκB kinase β (Yin et al, 1998) . Remarkably, NF-κB has an essential role in preventing tumour necrosis factor α and cancer therapy-induced apoptosis (Liu et al, 1996; Van Antwerp et al, 1996; Wang et al, 1996; Beg and Baltimore, 1996) . The elucidation of the mechanisms involved in the apoptotic action of aspirin in HT-29 cells needs further investigation.
Many cancer cells demonstrate reduced capabilities of responding to apoptotic stimuli (Hoffman and Liebermann, 1994) . The unusual features of aspirin-induced cell death in HT-29 cells may offer clues to the mechanisms by which cancer cells escape from apoptosis.
